Oppenheimer Asset Management Inc. Increases Stake in HealthEquity, Inc. $HQY

Oppenheimer Asset Management Inc. increased its holdings in HealthEquity, Inc. (NASDAQ:HQYFree Report) by 45.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 155,543 shares of the company’s stock after purchasing an additional 48,621 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in HealthEquity were worth $14,741,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in HQY. Norges Bank purchased a new position in shares of HealthEquity in the second quarter worth about $75,072,000. Westfield Capital Management Co. LP grew its position in HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after acquiring an additional 701,819 shares during the last quarter. AQR Capital Management LLC increased its stake in HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after purchasing an additional 661,795 shares during the period. Man Group plc increased its stake in HealthEquity by 1,331.8% in the 2nd quarter. Man Group plc now owns 254,652 shares of the company’s stock worth $26,677,000 after purchasing an additional 236,867 shares during the period. Finally, Viking Global Investors LP bought a new stake in HealthEquity in the second quarter valued at approximately $23,021,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HQY has been the topic of several recent analyst reports. The Goldman Sachs Group cut shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price on the stock. in a report on Friday, January 9th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $120.00 price target on shares of HealthEquity in a report on Friday, December 5th. Barclays assumed coverage on shares of HealthEquity in a research report on Monday, December 8th. They issued an “overweight” rating and a $118.00 price objective on the stock. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Monday, January 19th. Finally, KeyCorp raised their target price on HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a research note on Thursday, January 8th. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $119.60.

Get Our Latest Stock Report on HealthEquity

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares of the company’s stock, valued at $7,007,290.88. This trade represents a 1.99% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president owned 45,742 shares in the company, valued at approximately $4,366,073.90. This trade represents a 19.33% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 13,959 shares of company stock valued at $1,344,957 in the last three months. Corporate insiders own 1.50% of the company’s stock.

HealthEquity Stock Down 0.2%

Shares of NASDAQ HQY opened at $79.28 on Tuesday. The firm has a fifty day simple moving average of $90.10 and a two-hundred day simple moving average of $92.82. HealthEquity, Inc. has a 12 month low of $74.07 and a 12 month high of $116.65. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $6.77 billion, a PE ratio of 36.37, a price-to-earnings-growth ratio of 0.99 and a beta of 0.24.

HealthEquity (NASDAQ:HQYGet Free Report) last announced its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The company had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. During the same quarter in the previous year, the company earned $0.78 earnings per share. HealthEquity’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

About HealthEquity

(Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Read More

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.